One-Step Approach IDs More Cases of Gestational Diabetes
A one-step approach identifies more diagnoses of gestational diabetes, with no significant impact on perinatal or maternal complications.
Gestational Diabetes
Exercise Key to Lowering Risk for Gestational Diabetes
Exercise during the first trimester of pregnancy reduces the risks for abnormal glucose screening and gestational diabetes mellitus.
Machine Learning Models Can Predict Gestational Diabetes
Machine learning (ML) models are highly accurate for predicting gestational diabetes mellitus (GDM) in early pregnancy in a Chinese population.
Unique Metabolic Signature Predicts Transition to T2D After Gestational Diabetes
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
Guidance for Managing Gestational Diabetes During the COVID-19 Pandemic
Medical societies from the United Kingdom, Canada, and Australia have released recommendations for modification of testing during the COVID-19 pandemic.
Early Diagnosis of Gestational Diabetes Leads to Less Weight Gain
Early diagnosis and treatment of gestational diabetes mellitus (GDM) in high-risk women improves gestational weight gain.
Study Examines Use of T2D Genetic Risk Score in Women With a History of Gestational Diabetes
Among women with a history of gestational diabetes mellitus, a genetic risk score (GRS) is generally positively associated with type 2 diabetes risk.
REM-Related OSA Associated With Increased Gestational Diabetes Risk
Rapid eye movement-related obstructive sleep apnea and other sleep disordered breathing events are associated with an increased risk for gestational diabetes.
Longer Duration of Lactation Linked to Lower T2D Risk After Gestational Diabetes
Longer duration of lactation is associated with a lower risk for type 2 diabetes among women with a history of gestational diabetes mellitus.
Maternal Blood MFSD2a Levels as a Fetal Neurodevelopment Biomarker
The level of MFSD2a in maternal blood is a possible biomarker for disturbances of MFSD2a gene expression and may assist in predicting fetal neurodevelopment.
-
Loading...
-
Loading...
Next post in Diabetes
